Prayer and belief that God has a plan could lead to better outcomes for psychiatric illness patients receiving short-term treatment, a small new study suggests. David H. Rosmarin, HMS instructor in psychology in the Department of Psychiatry at McLean Hospital, is the lead investigator.
Scientists who dared to waste their time looking at the midbody, a remnant of cell division, have catapulted the organelle to new prominence. Tim Mitchison, the Hasib Sabbagh Professor of Systems Biology and deputy chairman of the Department of Systems Biology at HMS, is quoted.
A group of researchers has recently identified the first targeted therapy for a specific type of kidney disease, focal segmental glomerulosclerosis, or FSGS. Peter H. Mundel, HMS associate professor of medicine at Massachusetts General Hospital, led the team.
The days of scrawled doctor’s notes are slowly coming to a close. In the United States, 93 percent of hospitals are now using at least some electronic medical records and 2.2 percent have given up paper records completely, according to a new report. Robert C. Green, HMS associate professor of medicine at Brigham and Women’s Hospital and Daniel MacArthur, HMS assistant professor of medicine at Massachusetts General Hospital, are quoted.
A new Cambridge life-science company aims to develop therapies that can put troublesome genes under the knife, so to speak, cutting out bad DNA like a scalpel excises bad tissue. Cofounders of the company include George Church, HMS professor of genetics and member of the Wyss Institute, and Keith Joung, director of the molecular pathology unit at Massachusetts General Hospital.
